Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Almac Diagnostic Services to Build Pan-Cancer NGS Companion Test for TP Therapeutics

Almac Diagnostic Services to Build Pan-Cancer NGS Companion Test for TP Therapeutics

Oct 24, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Almac Diagnostic Services and precision oncology pharma TP Therapeutics said today that are collaborating to develop and commercialize a next-generation sequencing companion diagnostic for TP's repotrectinib, an investigational tyrosine kinase inhibitor targeting ROS1, NTRK1-3 and ALK gene fusions in advanced solid tumors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Infectious Disease Test Firm Talis Biomedical Files for IPO

  2. President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity

  3. NASA Looking to Spin Out Breath Analysis Platform for Use in Diagnostics Applications

    Premium

  4. NeoGenomics to Boost Growth of Pharma, Informatics Divisions Through CDx Agreements, Acquisitions

    Premium

  5. Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.